Morgan Stanley’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Sell |
|
|||||
|
2025
Q1 | $7.09M | Buy |
|
|||||
|
2024
Q4 | $7.85M | Buy |
|
|||||
|
2024
Q3 | $7.95M | Sell |
|
|||||
|
2024
Q2 | $7.85M | Buy |
|
|||||
|
2024
Q1 | $2.52M | Sell |
|
|||||
|
2023
Q4 | $2.27M | Buy |
|
|||||
|
2023
Q3 | $811K | Buy |
|
|||||
|
2023
Q2 | $1.04M | Sell |
|
|||||
|
2023
Q1 | $669K | Buy |
|
|||||
|
2022
Q4 | $776K | Sell |
|
|||||
|
2022
Q3 | $1.02M | Sell |
|
|||||
|
2022
Q2 | $919K | Buy |
|
|||||
|
2022
Q1 | $1.15M | Sell |
|
|||||
|
2021
Q4 | $2.74M | Buy |
|
|||||
|
2021
Q3 | $857K | Buy |
|
|||||
|
2021
Q2 | $896K | Buy |
|
|||||
|
2021
Q1 | $2K | Sell |
|
|||||
|
2020
Q4 | $264K | Buy |
|
|||||
|
2020
Q3 | $40K | Sell |
|
|||||
|
2020
Q2 | $110K | Buy |
|
|||||
|
2020
Q1 | $21K | Sell |
|
|||||
|
2019
Q4 | $450K | Buy |
|